Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA

PURPOSE: Ranibizumab, an anti-vascular endothelial growth factor, and dexamethasone, a corticosteroid, have been shown to be effective in treating macular oedema secondary to retinal vein occlusion (RVO) (central RVO (CRVO) and branch RVO (BRVO)). Their real-world usage, however, has yet to be compa...

Descripción completa

Detalles Bibliográficos
Autores principales: Nghiem-Buffet, S, Baillif, S, Regnier, S, Skelly, A, Yu, N, Sodi, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395996/
https://www.ncbi.nlm.nih.gov/pubmed/27911446
http://dx.doi.org/10.1038/eye.2016.269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395996/
https://www.ncbi.nlm.nih.gov/pubmed/27911446
http://dx.doi.org/10.1038/eye.2016.269

Ejemplares similares